Amgen (AMGN) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free AMGN Stock Alerts $295.77 -0.60 (-0.20%) (As of 09:58 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 10:07 AM | marketbeat.comFocus Financial Network Inc. ADV Takes Position in Amgen Inc. (NASDAQ:AMGN)Focus Financial Network Inc. ADV acquired a new stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,907 shares of the medical research companyMay 29 at 11:45 AM | marketbeat.comTD Asset Management Inc Has $162.10 Million Position in Amgen Inc. (NASDAQ:AMGN)TD Asset Management Inc trimmed its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 2.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 562,812 shares of the medical research company's stock after selling 13May 29 at 8:15 AM | fool.comWhere Will Amgen Be in 3 Years?May 29 at 12:20 AM | marketbeat.comAmgen Inc. (NASDAQ:AMGN) Shares Sold by Legacy Advisors LLCLegacy Advisors LLC lowered its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 21.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,155 shares of the medical research company's stock after selling 3,021 shares during the period.May 28 at 8:54 PM | finance.yahoo.comNvidia, advances in cancer research, climate change under Trump: Market DominationMay 28 at 6:37 PM | finance.yahoo.comTapping into the GLP-1 hype? Consider these pharma stocks.May 28 at 6:08 PM | reuters.comUS FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatmentMay 28 at 3:54 PM | msn.comDow's 325-point fall led by losses for Merck, Amgen stocksMay 28 at 1:37 PM | marketwatch.comMerck, Amgen share losses contribute to Dow's 225-point dropMay 28 at 9:00 AM | prnewswire.comAMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024May 27 at 2:25 PM | marketbeat.comBell & Brown Wealth Advisors LLC Takes $2.69 Million Position in Amgen Inc. (NASDAQ:AMGN)Bell & Brown Wealth Advisors LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 9,323 shares of the medical research company's stoMay 27 at 1:40 AM | americanbankingnews.comQ2 2024 EPS Estimates for Amgen Inc. Lowered by Zacks Research (NASDAQ:AMGN)May 27 at 1:40 AM | marketbeat.comQ2 2024 Earnings Estimate for Amgen Inc. (NASDAQ:AMGN) Issued By Zacks ResearchAmgen Inc. (NASDAQ:AMGN - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2024 earnings per share (EPS) estimates for Amgen in a report issued on Thursday, May 23rd. Zacks Research analyst S. Ganoria now forecasts that the medical research company will earn $4.85 perMay 26, 2024 | marketbeat.comHudson Value Partners LLC Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN)Hudson Value Partners LLC lifted its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 176.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,330 shares of the medical research company's stock after buyinMay 26, 2024 | fool.comAmgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?May 26, 2024 | americanbankingnews.comAmgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 26, 2024 | marketbeat.comAmgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Amgen Inc. (NASDAQ:AMGN - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-one analysts that are currently covering the stock, Marketbeat.com reports. Ten analysts have rated the stock with a hold recommendation and eleven have assigned a buy recMay 25, 2024 | marketbeat.comAdvisory Services Network LLC Cuts Stock Position in Amgen Inc. (NASDAQ:AMGN)Advisory Services Network LLC lessened its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 12.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 20,455 shares of the medical research company's stock afteMay 25, 2024 | finance.yahoo.comAmgen Inc. (AMGN)May 25, 2024 | finance.yahoo.comIt's Unlikely That Amgen Inc.'s (NASDAQ:AMGN) CEO Will See A Huge Pay Rise This YearMay 25, 2024 | americanbankingnews.comAmgen Inc. (NASDAQ:AMGN) Expected to Post Q3 2024 Earnings of $5.09 Per ShareMay 25, 2024 | marketbeat.comAmgen Inc. (NASDAQ:AMGN) is Primecap Management Co. CA's 3rd Largest PositionPrimecap Management Co. CA lowered its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 14,591,468 shares of the medical research company's stock after selling 140,990 shares during the quaMay 24, 2024 | marketbeat.comAmgen Inc. (NASDAQ:AMGN) to Post Q3 2024 Earnings of $5.09 Per Share, Zacks Research ForecastsAmgen Inc. (NASDAQ:AMGN - Free Report) - Analysts at Zacks Research increased their Q3 2024 earnings per share estimates for shares of Amgen in a report released on Thursday, May 23rd. Zacks Research analyst S. Ganoria now anticipates that the medical research company will earn $5.09 per share foMay 24, 2024 | investorplace.comStocks to Buy: 7 Undeniable Dow Darlings to Pile Into NowMay 24, 2024 | marketbeat.comGreylin Investment Management Inc Sells 14,707 Shares of Amgen Inc. (NASDAQ:AMGN)Greylin Investment Management Inc cut its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 48.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,860 shares of the medical research company's stock after sellingMay 23, 2024 | marketbeat.comAmgen Q1 Earnings TranscriptMay 22, 2024 | marketbeat.comBanco de Sabadell S.A Purchases New Stake in Amgen Inc. (NASDAQ:AMGN)Banco de Sabadell S.A purchased a new stake in Amgen Inc. (NASDAQ:AMGN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 7,816 shares of the medical research company's stock, valued at apprMay 22, 2024 | markets.businessinsider.comMaintaining Hold on Amgen: Mixed Clinical Results and Cautious Adoption of New TherapyMay 22, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Omnicell (OMCL), Tandem Diabetes Care (TNDM) and Amgen (AMGN)May 21, 2024 | marketbeat.comOxler Private Wealth LLC Acquires 3,272 Shares of Amgen Inc. (NASDAQ:AMGN)Oxler Private Wealth LLC boosted its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 54.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,323 shares of the medical research company's stock after purchasing an adMay 21, 2024 | seekingalpha.comAmgen Stock: Poised To Break Out (Technical Analysis)May 21, 2024 | investorplace.com7 Reliable Blue-Chip Stocks That Cannot MissMay 20, 2024 | seekingalpha.comAmgen, Inc. (AMGN) ATS and the Approval of IMDELLTRA Conference - (Transcript)May 20, 2024 | marketbeat.comAmgen Inc. (NASDAQ:AMGN) Shares Sold by Assetmark Inc.Assetmark Inc. trimmed its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 273,398 shares of the medical research company's stock after sMay 20, 2024 | investorplace.com7 Biotech Stocks That Could Breathe New Life Into Your PortfolioMay 20, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: AbSci (ABSI) and Amgen (AMGN)May 19, 2024 | marketbeat.comING Groep NV Raises Stake in Amgen Inc. (NASDAQ:AMGN)ING Groep NV increased its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 124.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 288,582 shares of the medical research company's stock after buying an additional 159,78May 19, 2024 | prnewswire.comNEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPDMay 18, 2024 | marketbeat.comBrown Advisory Inc. Boosts Stock Holdings in Amgen Inc. (NASDAQ:AMGN)Brown Advisory Inc. grew its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 350,328 shares of the medical research company's stock after acquiring anMay 18, 2024 | msn.comFDA Gives Accelerated Approval To Amgen's Drug For Small Cell Lung Cancer PatientsMay 18, 2024 | investing.comAnalysts weigh in on FDA's approval for Amgen's small cell cancer drugMay 17, 2024 | stocknews.com3 Biotech Stocks Poised for May SurgesMay 17, 2024 | fool.comMeet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo NordiskMay 17, 2024 | msn.comUS FDA approves Amgen drug for small cell lung cancerMay 16, 2024 | markets.businessinsider.comBalancing Early Approval and Market Challenges: Amgen’s Imdelltra Receives a Hold Rating from Carter GouldMay 16, 2024 | markets.businessinsider.comAmgen: FDA Approves Imdelltra For Extensive-Stage Small Cell Lung Cancer TreatmentMay 16, 2024 | msn.comAmgen wins FDA nod for new lung cancer therapyMay 16, 2024 | prnewswire.comFDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCERMay 16, 2024 | cnbc.comFDA approves Amgen's treatment for most deadly form of lung cancerMay 16, 2024 | reuters.comUS FDA approves Amgen drug for small cell lung cancer, Bloomberg reports Get Amgen News Delivered to You Automatically Sign up to receive the latest news and ratings for AMGN and its competitors with MarketBeat's FREE daily newsletter. Email Address The Tesla Indicator Is Bullish (Ad)If you ever thought you’re too late to see significant returns from Tesla stock… Please read this short email. Because a world class trading expert just showed me an entirely new way to target hefty returns inside shares of Tesla. It’s all thanks to one unique trade setup that’s specific to this legendary stock. It’s called the Perfect Tesla Trade. And it couldn’t be more straightforward… >> Click here to join Lance now and he’ll teach you how to execute the Perfect Tesla Trade inside yo AMGN Media Mentions By Week AMGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMGN News Sentiment▼0.700.80▲Average Medical News Sentiment AMGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMGN Articles This Week▼3420▲AMGN Articles Average Week Get Amgen News Delivered to You Automatically Sign up to receive the latest news and ratings for AMGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VRTX News Today REGN News Today GILD News Today MRNA News Today SGEN News Today BIIB News Today ALNY News Today BMRN News Today NBIX News Today INCY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMGN) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 MediaWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amgen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
